2.10
price up icon2.44%   0.05
after-market Dopo l'orario di chiusura: 2.08 -0.02 -0.95%
loading
Precedente Chiudi:
$2.05
Aprire:
$2.06
Volume 24 ore:
1.08M
Relative Volume:
0.77
Capitalizzazione di mercato:
$402.71M
Reddito:
-
Utile/perdita netta:
$-54.70M
Rapporto P/E:
-6.3636
EPS:
-0.33
Flusso di cassa netto:
$-51.36M
1 W Prestazione:
-4.11%
1M Prestazione:
-12.50%
6M Prestazione:
-31.60%
1 anno Prestazione:
-51.16%
Intervallo 1D:
Value
$2.03
$2.14
Intervallo di 1 settimana:
Value
$1.98
$2.29
Portata 52W:
Value
$1.89
$5.11

Savara Inc Stock (SVRA) Company Profile

Name
Nome
Savara Inc
Name
Telefono
51285113796
Name
Indirizzo
6836 BEE CAVE ROAD, AUSTIN, TX
Name
Dipendente
59
Name
Cinguettio
@SavaraPharma
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
SVRA's Discussions on Twitter

Confronta SVRA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SVRA
Savara Inc
2.10 402.71M 0 -54.70M -51.36M -0.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Savara Inc Stock (SVRA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-29 Downgrade H.C. Wainwright Buy → Neutral
2024-12-20 Iniziato Wells Fargo Overweight
2024-11-13 Downgrade Evercore ISI Outperform → In-line
2024-02-15 Iniziato JMP Securities Mkt Outperform
2023-11-07 Iniziato Guggenheim Buy
2023-05-16 Aggiornamento Jefferies Hold → Buy
2023-03-31 Downgrade Jefferies Buy → Hold
2021-03-16 Iniziato Piper Sandler Overweight
2021-03-15 Iniziato Oppenheimer Outperform
2019-06-13 Reiterato H.C. Wainwright Buy
2019-06-13 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2019-06-13 Downgrade Ladenburg Thalmann Buy → Neutral
2018-08-13 Ripresa ROTH Capital Neutral
2018-01-03 Iniziato Ladenburg Thalmann Buy
2017-09-27 Ripresa ROTH Capital Buy
2017-09-22 Iniziato Jefferies Buy
2017-09-11 Iniziato JMP Securities Mkt Outperform
Mostra tutto

Savara Inc Borsa (SVRA) Ultime notizie

pulisher
Jun 18, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc.SVRA - Bluefield Daily Telegraph

Jun 18, 2025
pulisher
Jun 18, 2025

Insiders Who Purchased US$783.7k Of Savara Stock May Not Have Expected 12% Tumble - simplywall.st

Jun 18, 2025
pulisher
Jun 14, 2025

Savara’s SWOT analysis: biotech firm’s stock poised for growth with aPAP drug - Investing.com

Jun 14, 2025
pulisher
Jun 13, 2025

Savara Inc (NASDAQ:SVRA) Stake Reduced by California State Teachers Retirement System - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $482,000 Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World

Jun 12, 2025
pulisher
Jun 09, 2025

Savara Inc (NASDAQ:SVRA) Shares Sold by Bank of America Corp DE - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Takes Position in Savara Inc (NASDAQ:SVRA) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Decreases Stock Holdings in Savara Inc (NASDAQ:SVRA) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

savara elects board members and approves proposals at annual meeting - Investing.com Australia

Jun 07, 2025
pulisher
Jun 06, 2025

savara elects board members and approves proposals at annual meeting By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Savara Re-elects Board Members at Annual Meeting - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Savara Inc (NASDAQ:SVRA) Shares Bought by Squarepoint Ops LLC - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

FDA Requests Additional Data for Savara’s MOLBREEVI Application - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Savara assumed with an Outperform at Oppenheimer - MSN

Jun 05, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Sells 30,766 Shares of Savara Inc (NASDAQ:SVRA) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Savara Inc. to Present at Jefferies Global Healthcare Conference on June 4, 2025 - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Millennium Management LLC Grows Stake in Savara Inc (NASDAQ:SVRA) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Savara Inc (NASDAQ:SVRA) Shares Bought by ProShare Advisors LLC - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Savara Inc.SVRA - FinancialContent

Jun 02, 2025
pulisher
Jun 02, 2025

Insider Buying Alert: Joseph Mccracken Acquires Additional Shares of Savara Inc (SVRA) - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer assumes Savara stock at outperform, sets $5 price target - Investing.com

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer assumes Savara stock at outperform, sets $5 price target By Investing.com - Investing.com Canada

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer Adjusts Price Target on Savara to $5 From $15, Maintains Outperform Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Oppenheimer Maintains Optimism for Savara (SVRA) Despite Filing Setback | SVRA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Savara director Joseph McCracken buys $20,825 in stock By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

Savara director Joseph McCracken buys $20,825 in stock - Investing.com Australia

Jun 02, 2025
pulisher
Jun 02, 2025

What is HC Wainwright’s Forecast for Savara FY2026 Earnings? - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Savara Inc (NASDAQ:SVRA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

May 31, 2025
pulisher
May 31, 2025

What is HC Wainwright’s Forecast for Savara FY2029 Earnings? - Defense World

May 31, 2025
pulisher
May 31, 2025

Savara Inc. Grants Equity Awards to New Employees - MSN

May 31, 2025
pulisher
May 30, 2025

FDA Denies Langhorne-Based Savara Application for Rare Lung Disease Treatment - BUCKSCO.Today

May 30, 2025
pulisher
May 30, 2025

Did Savara Inc. (SVRA) Mislead Investors? Levi & Korsinsky Investigates - ACCESS Newswire

May 30, 2025
pulisher
May 30, 2025

Savara (NASDAQ:SVRA) Lowered to “Neutral” Rating by HC Wainwright - Defense World

May 30, 2025
pulisher
May 29, 2025

SVRA: Savara Downgraded by HC Wainwright & Co. | SVRA Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Savara stock rating cut to Neutral by H.C. Wainwright - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

HC Wainwright & Co. Downgrades Savara (SVRA) - MSN

May 29, 2025
pulisher
May 29, 2025

This Starbucks Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga

May 29, 2025
pulisher
May 29, 2025

HC Wainwright Downgrades Savara to Neutral From Buy, Adjusts Price Target to $2 From $6 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright Lowers Savara (SVRA) Outlook Following FDA Setba - GuruFocus

May 29, 2025
pulisher
May 29, 2025

H.C. Wainwright Lowers Savara (SVRA) Outlook Following FDA Setback | SVRA Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Savara stock price target cut to $2 at Evercore ISI By Investing.com - Investing.com Canada

May 29, 2025
pulisher
May 29, 2025

Savara Inc (NASDAQ:SVRA) Shares Bought by D. E. Shaw & Co. Inc. - Defense World

May 29, 2025
pulisher
May 29, 2025

Guggenheim Reaffirms “Buy” Rating for Savara (NASDAQ:SVRA) - Defense World

May 29, 2025
pulisher
May 29, 2025

Savara (NASDAQ:SVRA) Given New $2.00 Price Target at Evercore ISI - Defense World

May 29, 2025
pulisher
May 29, 2025

Savara (NASDAQ:SVRA) Price Target Lowered to $7.00 at Wells Fargo & Company - Defense World

May 29, 2025
pulisher
May 29, 2025

SVRA ALERT: Levi & Korsinsky Investigates Savara Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire

May 29, 2025
pulisher
May 28, 2025

Savara Showcases Promising Phase 3 Trial Data for Molgramostim at ATS 2025 - MSN

May 28, 2025

Savara Inc Azioni (SVRA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Savara Inc Azioni (SVRA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
McCracken Joseph S
Director
May 29 '25
Buy
2.08
10,000
20,825
260,837
RAMSAY DAVID A
Director
Mar 31 '25
Buy
2.77
150,000
416,250
2,513,642
Lowrance David L
Chief Financial Officer
Dec 16 '24
Sale
3.33
25,000
83,278
381,005
Pauls Matthew
CHIEF EXECUTIVE OFFICER
Dec 16 '24
Sale
3.31
54,702
180,828
1,536,379
Hawkins Richard J
Director
Dec 16 '24
Sale
3.32
8,000
26,569
67,241
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):